Abstract ISI
JOURNAL OF CLINICAL ONCOLOGY  (2024)

Quantitative circulating tumor DNA (ctDNA) assessment in patients (pts) with advanced urothelial carcinoma (UC) treated with pembrolizumab (pembro) or platinum-based chemotherapy (chemo) from the phase 3 KEYNOTE-361 trial

Powles T.; Chang W.Y.H.; Yamamoto Y.; Munoz-Langa, J; Reyes F.; Peer A.; Yu E.Y.; Cohen G.; Lorch A.; Bavle A.; Moreno B.H.; Markensohn J.; Edmondson M.; Chen C.; Cristescu R.; et. al.